›››
Loading...
Loading...
Moderna — Model a full Wheel cycle: CSP entry, assignment, and CC exit
Moderna (MRNA) operates in the Health Care sector and has actively traded listed options. Entry requires ~$4,900 per contract — sell the CSP at a strike where ownership is acceptable. VRP at +7.6pp means implied vol overstates actual movement. IV Rank 45.4% puts premiums above the historical median. Viable — the statistical edge supports opening the wheel now. If assigned, rotate into covered calls to offset cost basis. See Covered Call for strike comparisons.
Wheel Cycle
Capital: ~$4,870Answer the question above to complete your assessment.
The Wheel strategy cycles between selling puts and covered calls. This page evaluates whether the current setup favors starting a Wheel position on this ticker.
Check if you'd be comfortable owning the stock at the put strike — that's the key Wheel decision.
Combines: capital requirement, IV Rank, VRP, signal strength, premium environment, liquidityStock price (for capital calc), IV Rank, VRP, bid-ask spreads, open interest
ORATS options data + VolRadar signal composite
The Wheel requires willingness to own shares at the put strike. Assignment risk is real — stock can drop significantly below your strike. Capital requirements vary with stock price.
After assignment on your cash secured put, the options wheel transitions to selling covered calls. These are the best current covered call opportunities to reduce cost basis:
Already own MRNA shares from a cash secured put assignment? These covered call and hedge strategies work with your existing position to generate income or protect gains.
Own shares + sell OTM call — generate income from existing position.
Same as Short Put but with full cash to buy shares at strike if assigned.
Buy deep ITM LEAPS call + sell short-term OTM call — like covered call but less capital.
Own shares + buy OTM put — insurance against downside while keeping upside.
Own shares + buy put + sell call — zero-cost or low-cost downside protection.
Quantitative screening, not investment advice. Verify with your broker. Disclaimer
At the current price, wheeling Moderna requires approximately $4,600 per contract — an accessible entry for most accounts. Lower capital requirements allow running multiple wheel positions simultaneously across different tickers, improving diversification. Start with a single contract to learn the mechanics before scaling.
Moderna currently shows a strong premium selling signal with favorable conditions across IV, VRP, and volatility regime. This is a supportive environment to initiate new wheel positions or roll existing ones. Strong signals historically correlate with options being overpriced relative to subsequent realized movement.
The wheel on Moderna follows a repeating cycle: (1) Sell a cash-secured put at a strike you are comfortable owning shares at. (2) If the put expires worthless, keep the premium and repeat. (3) If assigned, you now own 100 shares — sell covered calls at or above your cost basis. (4) Each covered call premium reduces your effective cost basis. The cycle compounds income over time, with the goal of generating consistent returns regardless of whether the stock moves up, down, or sideways.
Cash-secured: $4,600 per contract (100 shares x $46 strike). On margin (~20% requirement): approximately $920. Follow the 5% rule — no single wheel position should exceed 5% of your total account.
Most wheel traders sell puts 5–10% below current price (0.20–0.30 delta). For MRNA at $48.70, that means selling puts around $46–$44. In higher IV environments, you can sell further OTM while still collecting meaningful premium.
If assigned, you buy 100 shares at the put strike price. Your effective cost basis equals the strike minus premium collected (e.g., $46 - premium). Move to Phase 2: sell covered calls at or above your cost basis. Each call premium further reduces your cost basis.
Annualized returns vary with IV conditions. With current VRP of +7.6pp, the premium environment is strong for MRNA. Under favorable conditions, experienced wheel traders may target 15–30% annualized. Conservative 5% OTM strikes with 30–45 DTE tend to yield 12–20% annualized in normal conditions. The key variables are IV Rank (higher = richer premiums), strike distance (closer = more premium but higher assignment risk), and DTE (30–45 days is the theta decay sweet spot).
The biggest risk is assignment into a declining stock. If Moderna drops sharply below your put strike, you own 100 shares at a loss — and subsequent covered calls may not generate enough premium to recover before the stock falls further. At Moderna's current price of $48.70, assignment means holding $4,600 in a single position. To manage this: size each wheel to no more than 5% of your account, avoid selling CSPs into earnings, and confirm a positive VRP edge before entering.
Moderna currently shows a strong premium selling signal with favorable conditions for the wheel strategy. Key factors: IV Rank 45% (adequate for premium), earnings in 48 days.
Free embeddable tool: Wheel Calculator — add wheel strategy analysis to any site. No signup, no API key.
All P/L calculations exclude commissions, fees, and slippage. Premiums are model estimates (not live quotes) — verify with broker. Actual returns may differ significantly.
100 shares × $46 strike · On margin (~20%): ~$920
Sell call at or above cost basis ($44.68) to ensure profit if called away.
Assumes assignment at expiration. American-style options may be assigned early, especially near ex-dividend dates or deep ITM.